ArticleOPEN ACCESS

RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers

Molecular Oncology
DOI: 10.1002/1878-0261.12679
7Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Biswas, K., & Sharan, S. K. (2020, June 1). RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers. Molecular Oncology. John Wiley and Sons Ltd. https://doi.org/10.1002/1878-0261.12679

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free